Formulation and Optimisation of Sustained Release Spray-Dried Microspheres of Glipizide Using Natural Polysaccharide

References

1. 1.↵
   1. Wang A.,
   2. Wang Z.,
   3. Ma M.

   Review article—Pharmaceutical overview of tamarind gum, Int. J. Macromolecular Sci. 2011, 1 (1): 15–18.

   OpenUrl
2. 2.↵
   1. Rao P. S.,
   2. Ghosh T. P.,
   3. Krishna S.

   Extraction and purification of tamarind seed polysaccharide. J Sci. Ind. Res. 1946, 4, 705.

   OpenUrl
3. 3.↵
   1. Sano M.,
   2. Miyata E.,
   3. Tamano S.,
   4. Hagiwara A.,
   5. Ito N.,
   6. Shirai T.

   Lack of carcinogenicity of tamarind seed polysaccharide in B6C3F mice. Food Chem. Toxicol. 1996, 34 (5), 463–467.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Burgalassi S.,
   2. Panichi L.,
   3. Saettone M. F.,
   4. Jacobsen J.,
   5. Rassing M. R.

   Development and in vitro/in vivo testing of mucoadhesive buccal patches releasing benzydamine and lidocaine. Int. J. Pharm. 1996, 133 (1), 1–8.

   OpenUrl
5. 5.↵
   1. Kulkarni D.,
   2. Ddwivedi D. K.,
   3. Sarin J. P. S.,
   4. Singh S.

   Tamarind seed polyose: a potential polysaccharide for sustained release of verapamil hydrochloride as a model drug. Ind. J. Pharm. Sci. 1997, 59 (1), 1–7.

   OpenUrl
6. 6.↵
   1. Saettone M. F.,
   2. Burgalassi S.,
   3. Giannaccini B.,
   4. Boldrini E.,
   5. Bianchini P.,
   6. Luciani G.

   Ophthalmic Solutions Viscosified with Tamarind Seed Polysaccharide. U.S. Patent 6,056,950, 2000.
7. 7.↵
   1. Braga G. K.,
   2. Oliveira W. P.

   Manufacturing drug loaded chitosan microspheres by spray drying: development, characterization, and potential use in dentistry. Drying Technol. 2007, 25 (1–3), 303–310.

   OpenUrl
8. 8.↵
   1. Foster R. H.,
   2. Plosker G. L.

   Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus. Pharmacoeconomics 2000, 18 (3), 289–306.

   OpenUrlPubMed
9. 9.↵
   1. Dey N. S.,
   2. Majumdar S.,
   3. Rao M. E. B.

   Multiparticulate drug delivery systems for controlled release. Tropical Journal of Pharmaceutical Research 2008, 7 (3): 1067–1075.

   OpenUrl
10. 10.↵
    1. Patel J.,
    2. Patel R.,
    3. Amin A.,
    4. Patel M. M.

    Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech 2005, 6 (1), E49–E55.

    OpenUrlPubMed
11. 11.↵
    1. Behera B. C.,
    2. Sahoo S. K.,
    3. Dhal S.,
    4. Barik B. B.,
    5. Gupta B. K.

    Characterization of glipizide-loaded polymethacrylate microspheres prepared by an emulsion solvent evaporation method. Tropical Journal of Pharmaceutical Research 2008, 7 (1), 879–885.

    OpenUrl
12. 12.↵
    1. Bhalekar M.,
    2. Patil K.,
    3. Mohapatra S.

    ; Formulation optimization and in vivo evaluation of mucoadhesive xyloglucan microspheres. Pharm. Chem. J. 2011, 45 (8), 503–508.

    OpenUrl
13. 13.↵
    1. Sumathi S.,
    2. Ray A. R.

    Release behaviour of drugs from tamarind seed polysaccharide tablets. J. Pharm. Pharm. Sci. 2005, 5 (1), 12–18.

    OpenUrl
14. 14.↵
    1. Jana S.,
    2. Dibyendu L.,
    3. Sen K. K.,
    4. Basu S. K.

    Development and evaluation of epichlorohydrin cross-linked mucoadhesive patches of tamarind seed polysaccharide for buccal application. Intl. J. Pharm. Sci. Drug Res. 2010, 2 (3), 193–198.

    OpenUrl
15. 15.↵
    1. Wu L.,
    2. Yick K.-L.,
    3. Ng S.-P.,
    4. Yip J.

    Application of the Box-Behnken design to the optimization of process parameters in foam cup molding, Expert Systems with Applications 2012, 39 (9), 8059–8065.

    OpenUrl
16. 16.↵
    http://www.fda.gov/Draft guidance on glipizide accessed on 10^th Sept 2011.
17. 17.↵
    1. Dhakar R. C.,
    2. Sheo D. M.,
    3. Bhanu S.,
    4. Bhagat S.,
    5. Prajapati S. K.,
    6. Jain C. P.

    Variables Influencing the drug entrapment efficiency of microspheres: a pharmaceutical review. Der Pharmacia Lettre 2010, 2 (5), 102–116.

    OpenUrl
18. 18.↵
    1. Goncalves V. L.,
    2. Laranjeira M. C. M.,
    3. Valfredo T. F.,
    4. Pedrosa R. C.

    Effect of crosslinkng agent on chitosan microspheres in controlled release of Diclofenac sodium. Ciencia E Tecnologia 2005, 15 (1), 6–12.

    OpenUrl
19. 19.↵
    1. Kristmundsdottir T.,
    2. Gudmundsson S.,
    3. Ingvarsdottir K.

    Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int. J. Pharm. 1996, 137 (2), 159–165.

    OpenUrl
20. 20.↵
    1. Rao K. R.,
    2. Senapati P.,
    3. Das M. K.

    Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine. J. Microencapsulation 2005, 22 (8), 863–876.

    OpenUrlPubMed
21. 21.↵
    1. Costa P.,
    2. Sousa Lobo J. M.

    Modeling and comparison of dissolution profiles, Eur. J. of Pharm. Sci. 2001, 13 (2), 123–133.

    OpenUrl
22. 22.↵
    1. Motlekar N.

    Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres. Drug Des. Devel. Ther. 2008, 2, 39–47.

    OpenUrl
23. 23.↵
    1. Wand F. J.,
    2. Wang C. H.

    Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. J. Controlled Release 2002, 81 (3), 263–280.

    OpenUrlPubMed